자궁경부암 진단 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 검사 유형별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Cervical Cancer Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By End User, By Region & Competition, 2020-2030F
상품코드:1692299
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
자궁경부암 진단 세계 시장은 2024년 82억 7,000만 달러로 평가되며, 예측 기간 동안 6.24%의 CAGR로 2030년에는 118억 9,000만 달러에 달할 것으로 예상됩니다.
중년 여성의 자궁경부암 발병률 증가는 검진 및 진단 검사에 대한 수요 증가로 인해 향후 몇 년 동안 시장 성장을 견인할 것으로 예상됩니다. 세계보건기구(WHO)의 발표에 따르면, 자궁경부암은 전 세계 여성에서 4번째로 발병률이 높은 암으로 꼽히고 있습니다. 또한, 2023년 미국암협회 자료에 따르면, 미국에서는 약 13,960건의 침윤성 자궁경부암이 진단되어 약 4,310명의 여성이 사망할 것으로 추정됩니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
82억 7,000만 달러
시장 규모 : 2030년
118억 9,000만 달러
CAGR : 2025-2030년
6.24%
급성장 부문
팹 테스트
최대 시장
북미
시장 촉진요인
인식 제고와 교육
주요 시장 과제
의료 불평등
주요 시장 동향
분자진단 혁명
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 자궁경부암 진단 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
검사 종류별(팹 테스트, HPV 검사, 질경 검사, 자궁 경부 생검, 방광경 검사)
최종사용자별(병원·진료소, 진단 연구소, 기타)
지역별
기업별(2024)
제품 시장 맵
테스트 유형별
최종 용도별
지역별
제6장 북미의 자궁경부암 진단 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 자궁경부암 진단 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
영국
프랑스
이탈리아
스페인
제8장 아시아태평양의 자궁경부암 진단 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
일본
인도
호주
한국
제9장 남미의 자궁경부암 진단 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 자궁경부암 진단 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
쿠웨이트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
인수합병
제품 출시
제13장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제14장 경쟁 구도
Abbott Laboratories
Thermo Fisher Scientific Inc
Becton Dickinson and Company
Hologic Inc
CooperSurgical Inc
Siemens Healthineers AG
Quigan NV
F. Hoffmann-La Roche Ltd
Oncgnostics GmbH
Quest Diagnostics
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
Global Cervical Cancer Diagnostic Market was valued at USD 8.27 billion in 2024 and is expected to reach USD 11.89 billion by 2030 with a CAGR of 6.24% during the forecast period. The rise in cervical cancer rates among women in the middle age bracket is anticipated to drive market growth in the coming years due to the increased demand for screening and diagnostic tests. According to the World Health Organization's publications, cervical cancer is ranked as the fourth most prevalent cancer among women worldwide. Additionally, according to data from the American Cancer Society in 2023, it is estimated that approximately 13,960 cases of invasive cervical cancer will be diagnosed, resulting in approximately 4,310 female fatalities in the United States.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 8.27 Billion
Market Size 2030
USD 11.89 Billion
CAGR 2025-2030
6.24%
Fastest Growing Segment
Pap testing
Largest Market
North America
Key Market Drivers
Rising Awareness and Education
Cervical cancer is a formidable global health challenge, but increasing awareness and education are proving to be powerful catalysts for growth in the Global Cervical Cancer Diagnostic Market. The recognition of the importance of early detection and regular screenings is essential for reducing the burden of this disease. Awareness campaigns, educational programs, and advocacy efforts have been instrumental in empowering women with knowledge about cervical cancer and its prevention. These initiatives disseminate information about the disease, its risk factors, and the significance of regular screenings. As women become more informed, they are more likely to take proactive steps toward their health, including undergoing cervical cancer diagnostics.
Awareness and education campaigns stress the importance of early detection. Women who understand the benefits of regular screenings are more likely to schedule appointments with healthcare providers. This increased demand for screening services directly contributes to the growth of the cervical cancer diagnostic market. Cervical cancer screenings, such as Pap smears, can be intimidating for many women due to fear or discomfort. However, informed women are more likely to overcome these fears, knowing that early detection can be life-saving. Reducing the stigma and fear associated with cervical cancer diagnostics encourages more women to seek these services, further boosting market growth.
Key Market Challenges
Healthcare Inequity
Healthcare disparities exist in many parts of the world, and cervical cancer diagnostic services are not exempt from these inequalities. Women in marginalized communities often face barriers such as limited financial resources, lack of transportation, and inadequate healthcare infrastructure, which restrict their access to screening services.
Key Market Trends
Molecular Diagnostics Revolution
Molecular diagnostic techniques, including nucleic acid testing, have gained prominence in cervical cancer diagnosis. These methods offer increased sensitivity and specificity in detecting human papillomavirus (HPV) infections and identifying specific viral strains associated with cervical cancer. The trend is moving towards molecular testing becoming a standard procedure in cervical cancer screening, enabling more precise diagnoses.
Key Market Players
Abbott Laboratories
Thermo Fisher Scientific Inc
Becton Dickinson and Company
Hologic Inc
CooperSurgical Inc
Siemens Healthineers AG
Quigan NV
F. Hoffmann-La Roche Ltd
Oncgnostics GmbH
Quest Diagnostics
Report Scope:
In this report, the Global Cervical Cancer Diagnostic Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Cervical Cancer Diagnostic Market, By Test Type:
Pap testing
HPV testing
Colposcopy
Cervical biopsies
Cystoscopy
Cervical Cancer Diagnostic Market, By End User:
Hospitals & Clinics
Diagnostic Laboratories
Others
Cervical Cancer Diagnostic Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Cervical Cancer Diagnostic Market.
Available Customizations:
Global Cervical Cancer Diagnostic market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cervical Cancer Diagnostic Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Test Type (Pap testing, HPV testing, Colposcopy, Cervical biopsies, Cystoscopy)
5.2.2. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Product Market Map
5.3.1. By Test Type
5.3.2. By End Use
5.3.3. By Region
6. North America Cervical Cancer Diagnostic Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type (Pap testing, HPV testing, Colposcopy, Cervical biopsies, Cystoscopy)
6.2.2. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Cervical Cancer Diagnostic Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Test Type
6.3.1.2.2. By End Use
6.3.2. Canada Cervical Cancer Diagnostic Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Test Type
6.3.2.2.2. By End Use
6.3.3. Mexico Cervical Cancer Diagnostic Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Test Type
6.3.3.2.2. By End Use
7. Europe Cervical Cancer Diagnostic Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type (Pap testing, HPV testing, Colposcopy, Cervical biopsies, Cystoscopy)
7.2.2. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Cervical Cancer Diagnostic Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Test Type
7.3.1.2.2. By End Use
7.3.2. United Kingdom Cervical Cancer Diagnostic Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Test Type
7.3.2.2.2. By End Use
7.3.3. France Cervical Cancer Diagnostic Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Test Type
7.3.3.2.2. By End Use
7.3.4. Italy Cervical Cancer Diagnostic Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Test Type
7.3.4.2.2. By End Use
7.3.5. Spain Cervical Cancer Diagnostic Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Test Type
7.3.5.2.2. By End Use
8. Asia-Pacific Cervical Cancer Diagnostic Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type (Pap testing, HPV testing, Colposcopy, Cervical biopsies, Cystoscopy)
8.2.2. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Cervical Cancer Diagnostic Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Test Type
8.3.1.2.2. By End Use
8.3.2. Japan Cervical Cancer Diagnostic Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Test Type
8.3.2.2.2. By End Use
8.3.3. India Cervical Cancer Diagnostic Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Test Type
8.3.3.2.2. By End Use
8.3.4. Australia Cervical Cancer Diagnostic Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Test Type
8.3.4.2.2. By End Use
8.3.5. South Korea Cervical Cancer Diagnostic Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Test Type
8.3.5.2.2. By End Use
9. South America Cervical Cancer Diagnostic Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Test Type (Pap testing, HPV testing, Colposcopy, Cervical biopsies, Cystoscopy)
9.2.2. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Cervical Cancer Diagnostic Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Test Type
9.3.1.2.2. By End Use
9.3.2. Argentina Cervical Cancer Diagnostic Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Test Type
9.3.2.2.2. By End Use
9.3.3. Colombia Cervical Cancer Diagnostic Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Test Type
9.3.3.2.2. By End Use
10. Middle East and Africa Cervical Cancer Diagnostic Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Test Type (Pap testing, HPV testing, Colposcopy, Cervical biopsies, Cystoscopy)
10.2.2. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Cervical Cancer Diagnostic Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Test Type
10.3.1.2.2. By End Use
10.3.2. Saudi Arabia Cervical Cancer Diagnostic Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Test Type
10.3.2.2.2. By End Use
10.3.3. UAE Cervical Cancer Diagnostic Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Test Type
10.3.3.2.2. By End Use
10.3.4. Kuwait Cervical Cancer Diagnostic Market Outlook
